Everolimus Plus Letrozole for Treatment of Patients With HR+, HER2– Advanced Breast Cancer Progressing on Endocrine Therapy: An Open-label, Phase II Trial
2018 ◽
Vol 18
(2)
◽
pp. e197-e203
◽
Keyword(s):
Phase Ii
◽